Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Antioxidants (Basel, Switzerland)|July 2, 2021
Opportunities for Ferroptosis in Cancer TherapyKenji M Fujihara, Bonnie Z Zhang, Nicholas J ClemonsFrontiers in Molecular Biosciences|May 9, 2024
Modelling esophageal adenocarcinoma and Barrett's esophagus with patient-derived organoidsJulia V Milne, Ebtihal H Mustafa, Nicholas J ClemonsCancer Biology & Therapy|June 25, 2013
Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junctionNicholas J Clemons, Wayne A Phillips, Reginald V LordDiscovery Medicine|January 14, 2014
Advances in understanding the pathogenesis of Barrett's esophagusNicholas J Clemons, Shze Yung Koh, Wayne A PhillipsGastroenterology|October 9, 2007
Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanismsNicholas J Clemons, Kenneth E L McColl, Rebecca C FitzgeraldThe Journal of Biological Chemistry|January 6, 2005
Hsp72 inhibits Fas-mediated apoptosis upstream of the mitochondria in type II cellsNicholas J Clemons, Katherine Buzzard, Rohan Steel, et al.Gastroenterology|October 4, 2021
Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal CancerDingzhi Wang, Carlos S Cabalag, Nicholas J Clemons, et al.Annals of the New York Academy of Sciences|July 6, 2018
Preclinical models for the study of Barrett's carcinogenesisMatthew D Read, Kausilia K Krishnadath, Nicholas J Clemons, et al.Molecular & Cellular Oncology|October 24, 2017
Inhibiting system xC- and glutathione biosynthesis - a potential Achilles' heel in mutant-p53 cancersNicholas J Clemons, David S Liu, Cuong P Duong, et al.Discovery Medicine|February 2, 2017
Preclinical models of esophageal adenocarcinoma for drug developmentDavid S Liu, Cuong P Duong, Wayne A Phillips, et al.Pageof 6